|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fuller GN and Scheithauer BW: The 2007
Revised World Health Organization (WHO) Classification of Tumours
of the Central Nervous System: newly codified entities. Brain
Pathol. 17:304–307. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Galli R, Binda E, Orfanelli U, et al:
Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
5
|
Bao S, Wu Q, McLendon RE, et al: Glioma
stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sakariassen PO, Immervoll H and Chekenya
M: Cancer stem cells as mediators of treatment resistance in brain
tumors: status and controversies. Neoplasia. 9:882–892. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Eyler CE and Rich JN: Survival of the
fittest: cancer stem cells in therapeutic resistance and
angiogenesis. J Clin Oncol. 26:2839–2845. 2008. View Article : Google Scholar
|
|
8
|
Clarke MF, Dick JE, Dirks PB, et al:
Cancer stem cells - perspectives on current status and future
directions: AACR Workshop on cancer stem cells. Cancer Res.
66:9339–9344. 2006. View Article : Google Scholar
|
|
9
|
Liu Q, Nguyen DH, Dong Q, et al: Molecular
properties of CD133+ glioblastoma stem cells derived
from treatment-refractory recurrent brain tumors. J Neurooncol.
94:1–19. 2009.
|
|
10
|
Spencer DD, Robbins RJ, Naftolin F, et al:
Unilateral transplantation of human fetal mesencephalic tissue into
the caudate nucleus of patients with Parkinson’s disease. N Engl J
Med. 327:1541–1548. 1992.
|
|
11
|
Freed CR, Breeze RE, Rosenberg NL, et al:
Survival of implanted fetal dopamine cells and neurologic
improvement 12 to 46 months after transplantation for Parkinson’s
disease. N Engl J Med. 327:1549–1555. 1992.PubMed/NCBI
|
|
12
|
Imitola J, Raddassi K, Park KI, et al:
Directed migration of neural stem cells to sites of CNS injury by
the stromal cell-derived factor 1alpha/CXC chemokine receptor 4
pathway. Proc Natl Acad Sci USA. 101:18117–18122. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Armstrong RJ and Svendsen CN: Neural stem
cells: from cell biology to cell replacement. Cell Transplant.
9:139–152. 2000.PubMed/NCBI
|
|
14
|
Carbajal KS, Schaumburg C, Strieter R,
Kane J and Lane TE: Migration of engrafted neural stem cells is
mediated by CXCL12 signaling through CXCR4 in a viral model of
multiple sclerosis. Proc Natl Acad Sci USA. 107:11068–11073. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Aboody KS, Brown A, Rainov NG, et al:
Neural stem cells display extensive tropism for pathology in adult
brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA.
97:12846–12851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benedetti S, Pirola B, Pollo B, et al:
Gene therapy of experimental brain tumors using neural progenitor
cells. Nat Med. 6:447–450. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
17
|
Herrlinger U, Woiciechowski C,
Sena-Esteves M, et al: Neural precursor cells for delivery of
replication-conditional HSV-1 vectors to intracerebral gliomas. Mol
Ther. 1:347–357. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Staflin K, Honeth G, Kalliomaki S,
Kjellman C, Edvardsen K and Lindvall M: Neural progenitor cell
lines inhibit rat tumor growth in vivo. Cancer Res. 64:5347–5354.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Glass R, Synowitz M, Kronenberg G, et al:
Glioblastoma-induced attraction of endogenous neural precursor
cells is associated with improved survival. J Neurosci.
25:2637–2646. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yip S, Sabetrasekh R, Sidman RL and Snyder
EY: Neural stem cells as novel cancer therapeutic vehicles. Eur J
Cancer. 42:1298–1308. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim SU: Neural stem cell-based gene
therapy for brain tumors. Stem Cell Rev. 7:130–140. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Spencer D: Fighting brain tumors while
protecting the brain: the stem cell story. Neurology. 76:e69–e70.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu JJ, Sun X, Yuan X, Lee JW, Snyder EY
and Yu JS: Immunomodulatory neural stem cells for brain tumour
therapy. Expert Opin Biol Ther. 6:1255–1262. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ahmed AU, Alexiades NG and Lesniak MS: The
use of neural stem cells in cancer gene therapy: predicting the
path to the clinic. Curr Opin Mol Ther. 12:546–552. 2010.PubMed/NCBI
|
|
25
|
Aboody KS, Najbauer J and Danks MK: Stem
and progenitor cell-mediated tumor selective gene therapy. Gene
Ther. 15:739–752. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang SJ, Ye F, Xie RF, et al: Comparative
study on the stem cell phenotypes of C6 cells under different
culture conditions. Chin Med J. 124:3118–3126. 2011.PubMed/NCBI
|
|
27
|
Campos B, Wan F, Farhadi M, et al:
Differentiation therapy exerts antitumor effects on stem-like
glioma cells. Clin Cancer Res. 16:2715–2728. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Laks DR, Masterman-Smith M, Visnyei K, et
al: Neurosphere formation is an independent predictor of clinical
outcome in malignant glioma. Stem Cells. 27:980–987. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang S, Luo X, Wan F and Lei T: The roles
of hypoxia-inducible factors in regulating neural stem cells
migration to glioma stem cells and determinating their fates.
Neurochem Res. 37:2659–2666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Busletta C, Novo E, Valfre DBL, et al:
Dissection of the biphasic nature of hypoxia-induced motogenic
action in bone marrow-derived human mesenchymal stem cells. Stem
Cells. 29:952–963. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kendall SE, Najbauer J, Johnston HF, et
al: Neural stem cell targeting of glioma is dependent on
phosphoinositide 3-kinase signaling. Stem Cells. 26:1575–1586.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schmidt NO, Przylecki W, Yang W, et al:
Brain tumor tropism of transplanted human neural stem cells is
induced by vascular endothelial growth factor. Neoplasia.
7:623–629. 2005. View Article : Google Scholar
|
|
33
|
Mercapide J, Rappa G, Anzanello F, King J,
Fodstad O and Lorico A: Primary gene-engineered neural
stem/progenitor cells demonstrate tumor-selective migration and
antitumor effects in glioma. Int J Cancer. 126:1206–1215. 2010.
|
|
34
|
Pollard SM, Conti L, Sun Y, Goffredo D and
Smith A: Adherent neural stem (NS) cells from fetal and adult
forebrain. Cereb Cortex. 16(Suppl 1): i112–i120. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Sun Y, Pollard S, Conti L, et al:
Long-term tripotent differentiation capacity of human neural stem
(NS) cells in adherent culture. Mol Cell Neurosci. 38:245–258.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pollard SM, Yoshikawa K, Clarke ID, et al:
Glioma stem cell lines expanded in adherent culture have
tumor-specific phenotypes and are suitable for chemical and genetic
screens. Cell Stem Cell. 4:568–580. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Xu Q, Wang S, Jiang X, et al:
Hypoxia-induced astrocytes promote the migration of neural
progenitor cells via vascular endothelial factor, stem cell factor,
stromal-derived factor-1alpha and monocyte chemoattractant
protein-1 upregulation in vitro. Clin Exp Pharmacol Physiol.
34:624–631. 2007. View Article : Google Scholar
|
|
38
|
Zhao D, Najbauer J, Garcia E, et al:
Neural stem cell tropism to glioma: critical role of tumor hypoxia.
Mol Cancer Res. 6:1819–1829. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pistollato F, Abbadi S, Rampazzo E, et al:
Intratumoral hypoxic gradient drives stem cells distribution and
MGMT expression in glioblastoma. Stem Cells. 28:851–862.
2010.PubMed/NCBI
|
|
40
|
Chirasani SR, Sternjak A, Wend P, et al:
Bone morphogenetic protein-7 release from endogenous neural
precursor cells suppresses the tumourigenicity of stem-like
glioblastoma cells. Brain. 133:1961–1972. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kim SK, Kim SU, Park IH, et al: Human
neural stem cells target experimental intracranial medulloblastoma
and deliver a therapeutic gene leading to tumor regression. Clin
Cancer Res. 12:5550–5556. 2006. View Article : Google Scholar
|
|
42
|
van Eekelen M, Sasportas LS, Kasmieh R, et
al: Human stem cells expressing novel TSP-1 variant have
anti-angiogenic effect on brain tumors. Oncogene. 29:3185–3195.
2010.PubMed/NCBI
|
|
43
|
Ehtesham M, Kabos P, Gutierrez MA, et al:
Induction of glioblastoma apoptosis using neural stem cell-mediated
delivery of tumor necrosis factor-related apoptosis-inducing
ligand. Cancer Res. 62:7170–7174. 2002.
|
